- $61.63bn
- $68.39bn
- $11.81bn
- 79
- 30
- 98
- 78
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,740 | 11,497 | 12,222 | 11,915 | 11,812 |
Cost of Revenue | |||||
Gross Profit | 4,545 | 6,483 | 6,787 | 5,447 | 5,113 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6,017 | 8,861 | 10,977 | 11,712 | 13,475 |
Operating Profit | 3,723 | 2,636 | 1,245 | 203 | -1,663 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,693 | 3,143 | 1,108 | -51 | -2,031 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,861 | 2,439 | 10 | -506 | -2,557 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2,805 | 2,829 | 1,166 | -429 | -2,494 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,805 | 2,829 | 1,166 | -429 | -2,494 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.58 | 3.22 | 1.89 | 0.697 | -1.12 |
Dividends per Share | |||||
Special Dividends per Share |